Clinical Trials Directory

Trials / Unknown

UnknownNCT02906384

Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC)

Memory Preservation and Functional Brain Magnetic Resonance Imaging Changes With Conformal Avoidance of the Hippocampal Neural Stem-cell Compartment During Prophylactic Cranial Irradiation for Small Cell Lung Cancer Patients: A Prospective, Randomized Phase-II Study

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
154 (estimated)
Sponsor
Zhejiang Cancer Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, randomized phase-II study observing the memory preservation and functional brain MRI changes with conformal avoidance of the hippocampal neural stem-cell compartment during prophylactic cranial irradiation for small cell lung cancer patients.

Detailed description

Brain metastasis is rather high in small cell lung cancer patients. Prophylactic cranial irradiation(PCI) is the standardized treatment. However, cognitive dysfunction like memory damage is observed in quite a number of patients after brain irradiation, which may due to the hippocampus being irradiated. Thus, the investigators conduct the study by reducing the dose to the hippocampal neural stem-cell compartment (HAZ) during PCI. Patient Population: Age: 18-65y; small cell lung cancer undergoing PCI; Eastern Cooperative Oncology Group (ECOG) score: 0-1. The patients are randomized to 2 arms: Arm Routine PCI: PTV(planning target volume) 25Gy/10F. Arm Hippocampus avoidance PCI(HA-PCI): PTV 25Gray(Gy)/10Fraction(F), HAZ Dmin\<9Gy Dmax\<16Gy). Measurements: Hopkins verbal learning test(HVLT) and functional brain magnetic resonance imaging.

Conditions

Interventions

TypeNameDescription
RADIATIONhippocampus avoidanceconformal avoidance of the hippocampal neural stem-cell compartment during prophylactic cranial irradiation

Timeline

Start date
2016-10-01
Primary completion
2018-10-01
Completion
2020-10-01
First posted
2016-09-20
Last updated
2016-10-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02906384. Inclusion in this directory is not an endorsement.